首页> 外国专利> MIRNA-BASED PREDICTIVE MODELS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER

MIRNA-BASED PREDICTIVE MODELS FOR DIAGNOSIS AND PROGNOSIS OF PROSTATE CANCER

机译:基于MiRNA的预测模型,用于诊断和预后前列腺癌

摘要

The lack of clear predictors of prostate cancer progression leads to subjective decision-making regarding courses of treatment. The identification of new biomarkers that are predictive of recurrence after radical prostatectomy would advance the field of prostate cancer treatment. Disclosed are miRNAs that can be used as molecular biomarkers to detect or predict the progression of prostate cancer and to adjust a treatment plan accordingly. Furthermore, kits are included for the detection of these miRNAs.
机译:前列腺癌进展的缺乏明确的预测因子导致关于治疗课程的主观决策。在自由基前列腺切除术后,鉴定预测复发性的新生物标志物将推进前列腺癌治疗领域。公开了MIRNA,其可用作分子生物标志物以检测或预测前列腺癌的进展并相应地调整治疗计划。此外,包括试剂盒用于检测这些miRNA。

著录项

相似文献

  • 专利
  • 外文文献
  • 中文文献
获取专利

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号